Asymmetric Reductive Amination Catalysts for Asymmetric Reductive Amination
–Ir-PSA series–




Ir-PSA

Kanto Chemical has developed novel asymmetric reductive amination catalysts,Ir-PSA for preparation of optically active amines。
Optically active amines are important compounds such as intermediates of pharmaceuticals。Conventional methods for synthesis of optically active amines include optical resolution of racemic amines and enantioselective or diastereoselective reduction of pre-prepared imines。These were not efficient methods due to low yield,long steps and poor functional group tolerance。Therefore,we improved our original reductive amination catalysts(Ir-Pa,Ir-QN)into asymmetric catalysts(Ir-PSA)and developed an efficient method for preparation of optically active amines。In this method,combination of chiral Ir-PSA and an inexpensive aminoalcohol-based chiral auxiliary enables efficient asymmetric reductive amination of ketones to afford corresponding optically actives in high yield and high stereoselectivity。It is especially effective for amines that are difficult to obtain by conventional asymmetric synthesis。And the aminoalcohol moiety can be easily and quantitatively removed under mild oxidative conditions。This method is a practical reaction with excellent functional group tolerance。Ir-PSA are available in both S and R enantiomers。Ir-PSA18is especially effective for the asymmetric reductive amination of phenylacetones,and Ir-PSA36is effective for the 2-tetralones。

Reaction examples by Ir-PSA 18

Reaction examples by Ir-PSA 36

组合式配电装置


This method exhibits superior stereoselectivity compared to sodium borohydride reduction and Pd catalytic hydrogenation。

应用程序到Rotigotine intermediate synthesis


The optical purity can be easily increased by recrystallization of the diastereomeric intermediate。

应用程序到Tamsulosin intermediate synthesis


Process shortening and cost reduction can be expected in optically active amine synthesis。

产品列表

产品,产品 产品,产品 Grade 产品编号。 包装,包装
S、S-Ir-PSA18
Chloro[(S、S-N-{1-(4-pyridin-2-yl(2,4,6-trimethylphenyl)methyl}methanesulfonamidato(pentamethylcyclopentadienyl)iridium(III)
asymmetric synthesis 07060-68 100mg
R-Ir-PSA18
Chloro[(R-N-{1-(4-pyridin-2-yl(2,4,6-trimethylphenyl)methyl}methanesulfonamidato(pentamethylcyclopentadienyl)iridium(III)
asymmetric synthesis 07071-68 100mg
S、S-Ir-PSA36
Chloro[(S、S-N-(1-(4-methoxy-3,5-dimethylpyridin-2-yl)-1-phenylethyl)methanesulfonamidato
asymmetric synthesis 07658-68 100mg
R-Ir-PSA36
Chloro[(R-N-(1-(4-methoxy-3,5-dimethylpyridin-2-yl)-1-phenylethyl)methanesulfonamidato
asymmetric synthesis 07035-68 100mg
L-Valinol   44078-32
25g
44078-52 5g
R)-(-)-2-Amino-3-methyl-1-butanol   42247-2A 5g
S、S)-(+)-Phenylglycinol   30757-1A 1g
D(-)-α-Phenylglycinol   18382-1A 5g
NaIO4个 Sodium periodate Guaranteed reagent for JIS 37233-00 500克
37233-20 100g
37233-30 25g
H5IO6个 方向,方向,方向 Guaranted reagent 32061-30 25g
S、S-2-Amino-5-methoxytetralin hydrochloride asymmetric synthesis 01770-55 5g
S、S)-2-Amino-5-methoxytetralin(S、S-mandelate asymmetric synthesis 01769-55 5g

Patent application by Kanto Chemical Co。

应用程序编号

  • WO2014175267
  • JP2022-075375
  • JP2022-075379

相关信息

公共,公共

 

接触Us

E-mail Inquiry Form

Inquiry Form

Telephone

+81-3-6214-1092